Lonza is responsible for manufacturing proprietary tech components and Sidewinder for ADC, R&D, manufacturing, and commercialization.

Researchers say discoveries could expand the CRISPR toolbox and lead to more efficient, rapid diagnostic tools for detecting COVID-19, influenza, and RSV.

Gene therapy ‘switch’ may offer non-addictive pain relief. New approach targets pain signals while leaving the rest of the brain untouched.

Purpose-built electronic quality management systems are a better fit for CGT production than traditional technologies.

GEN’s first virtual event of 2026—we present a group of outstanding researchers and thought-leaders to discuss the latest advances and challenges in delivering genetic therapies.

Formerly Somite AI, the rebranded company aims to broaden the regenerative medicine landscape by building AI models that ...

In addition, Der Simulierte Mensch (Si-M), The Simulated Human, a new research center, is being finalized in Berlin to open in 2026. Neubauer explains this is a joint partnership between TU Berlin and ...

Endophytic fungus from from Madagascar periwinkle offers a greener, cheaper way to produce the cancer drug vinblastine.

With a growing number of exosome-based delivery vehicles advancing into the clinic for therapeutics and vaccines, more effective isolation and separation strategies are needed. Finnish researchers ...

PEGASUS generates permeable macrocyclic peptides, offering new promise for a modality that can combine the properties of a biologic in a pill ...

Eli Lilly will partner with Nimbus Therapeutics to develop an oral treatment for obesity and other metabolic diseases, through a multi-year research collaboration and exclusive worldwide license ...

A newly identified and rare genetic variant slows the growth of mutated blood stem cells and reduces the risk of leukemia.